ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
10.50
0.00 (0.00%)
Apr 28, 2026, 10:57 AM CET
64.06%
Market Cap 97.46M
Revenue (ttm) 8.90M
Net Income (ttm) -10.40M
Shares Out 9.28M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,851
Average Volume 1,016
Open 11.00
Previous Close 10.50
Day's Range 10.50 - 11.00
52-Week Range 5.98 - 17.40
Beta 0.73
RSI 48.49
Earnings Date May 7, 2026

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 7
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2025, ViroGates's revenue was 8.90 million, an increase of 24.67% compared to the previous year's 7.14 million. Losses were -10.40 million, -27.52% less than in 2024.

Financial Statements

News

There is no news available yet.